Ifosfamide Injection shortage
Current 8 presentations · 4 manufacturers · first FDA posting 2026-06-12 · last update 2026-10-15
Manufacturers: Baxter Healthcare, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., SteriMax, Inc.
Stated reasons (per FDA): Demand increase for the drug; Requirements related to complying with good manufacturing practices
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) | Baxter Healthcare | Current Available |
— | Posted 06/12/2026 Updated 10/02/2026 | |
| IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) | Baxter Healthcare | Current Unavailable |
Requirements related to complying with good manufacturing practices | Estimated recovery: November 2026 | Posted 06/12/2026 Updated 10/02/2026 |
| Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) | Baxter Healthcare | Current Available |
— | Posted 06/12/2026 Updated 10/02/2026 | |
| Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) | Baxter Healthcare | Current Available |
— | Posted 06/12/2026 Updated 10/02/2026 | |
| Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) | Fresenius Kabi USA, LLC | Current Limited Availability |
Demand increase for the drug | Check wholesalers for inventory | Posted 06/12/2026 Updated 10/15/2026 |
| Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Posted 06/12/2026 Updated 10/14/2026 |
| Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. | Posted 06/12/2026 Updated 10/14/2026 |
| Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02) | SteriMax, Inc. | Current Available |
— | To place an order, please contact GlobalRX at [email protected] or (919) 245-8418 | Posted 06/12/2026 Updated 09/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)